ANI PHARMACEUTICALS, INC Current Assets
ANI PHARMACEUTICALS, INC (ANIP) had Current Assets of $825.43 million as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2026-08-07
- 2026-06-30: Assets, Current $825.43M.
- 2026-03-31: Assets, Current $747.08M.
- 2025-12-31: Assets, Current $753.12M.
- 2025-09-30: Assets, Current $698.40M.
| Period end | Assets, Current | Assets, Current as first filed |
|---|---|---|
| 2026-06-30 | $825.43M 10-Q · filed 2026-08-07 | |
| 2026-03-31 | $747.08M 10-Q · filed 2026-05-08 | |
| 2025-12-31 | $753.12M 10-Q · filed 2026-08-07 | |
| 2025-09-30 | $698.40M 10-Q · filed 2025-11-07 | |
| 2025-06-30 | $602.63M 10-Q · filed 2025-08-08 | |
| 2025-03-31 | $536.29M 10-Q · filed 2025-05-09 | |
| 2024-12-31 | $528.46M 10-K · filed 2026-02-27 | $527.68M 10-K · filed 2025-02-28 |
| 2024-09-30 | $521.30M 10-Q · filed 2024-11-08 | |
| 2024-06-30 | $555.46M 10-Q · filed 2024-08-06 | |
| 2024-03-31 | $540.56M 10-Q · filed 2024-05-10 | |
| 2023-12-31 | $519.82M 10-K · filed 2025-02-28 | |
| 2023-09-30 | $497.22M 10-Q · filed 2023-11-08 | |
| 2023-06-30 | $459.31M 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $364.75M 10-Q · filed 2023-05-08 | |
| 2022-12-31 | $344.26M 10-K · filed 2024-02-29 | |
| 2022-09-30 | $309.38M 10-Q · filed 2022-11-09 | |
| 2022-06-30 | $322.40M 10-Q · filed 2022-08-08 | |
| 2022-03-31 | $301.40M 10-Q · filed 2022-05-10 | |
| 2021-12-31 | $321.77M 10-K · filed 2023-03-09 | |
| 2021-09-30 | $191.38M 10-Q · filed 2021-11-01 | |
| 2021-06-30 | $191.80M 10-Q · filed 2021-08-06 | |
| 2021-03-31 | $182.80M 10-Q · filed 2021-05-07 | |
| 2020-12-31 | $170.32M 10-K · filed 2022-03-15 | |
| 2020-09-30 | $165.82M 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $156.54M 10-Q · filed 2020-08-06 | |
| 2020-03-31 | $158.66M 10-Q · filed 2020-05-07 | |
| 2019-12-31 | $187.69M 10-K · filed 2021-03-11 | |
| 2019-09-30 | $182.39M 10-Q · filed 2019-11-06 | |
| 2019-06-30 | $168.91M 10-Q · filed 2019-08-07 | |
| 2019-03-31 | $151.83M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $152.88M 10-K · filed 2020-02-27 | |
| 2018-09-30 | $156.79M 10-Q · filed 2018-11-06 | |
| 2018-06-30 | $152.37M 10-Q · filed 2018-08-07 | |
| 2018-03-31 | $143.39M 10-Q · filed 2018-05-08 | |
| 2017-12-31 | $131.60M 10-K · filed 2019-02-27 | |
| 2017-09-30 | $125.58M 10-Q · filed 2017-11-02 | |
| 2017-06-30 | $112.86M 10-Q · filed 2017-08-03 | |
| 2017-03-31 | $106.98M 10-Q · filed 2017-05-04 | |
| 2016-12-31 | $103.01M 10-K · filed 2018-02-27 | |
| 2016-09-30 | $95.47M 10-Q · filed 2016-11-03 | |
| 2016-06-30 | $79.82M 10-Q · filed 2016-08-04 | |
| 2016-03-31 | $116.55M 10-Q · filed 2016-05-05 | |
| 2015-12-31 | $192.58M 10-K · filed 2017-03-02 | |
| 2015-09-30 | $197.52M 10-Q · filed 2015-11-03 | |
| 2015-06-30 | $208.95M 10-Q · filed 2015-08-04 | |
| 2015-03-31 | $202.99M 10-Q · filed 2015-05-05 | |
| 2014-12-31 | $194.99M 10-K · filed 2016-02-23 | $203.48M 10-K · filed 2015-02-23 |
| 2014-09-30 | $57.56M 10-Q · filed 2014-11-10 | |
| 2014-06-30 | $67.16M 10-Q · filed 2014-08-07 | |
| 2014-03-31 | $67.94M 10-Q · filed 2014-05-12 | |
| 2013-12-31 | $27.72M 10-K · filed 2015-02-23 | |
| 2013-09-30 | $26.09M 10-Q · filed 2013-11-07 | |
| 2013-06-30 | $24.12M 10-Q · filed 2013-08-09 | |
| 2013-03-31 | $31.93M 10-Q · filed 2013-05-10 | |
| 2012-12-31 | $8.57M 10-K · filed 2014-02-28 | $35.17M 10-K · filed 2013-02-28 |
| 2012-09-30 | $38.58M 10-Q · filed 2012-11-08 | |
| 2012-06-30 | $42.93M 10-Q · filed 2012-08-01 | |
| 2012-03-31 | $50.19M 10-Q · filed 2012-05-08 | |
| 2011-12-31 | $58.03M 10-K · filed 2013-02-28 | |
| 2011-09-30 | $70.54M 10-Q · filed 2011-11-09 | |
| 2011-06-30 | $38.14M 10-Q · filed 2011-08-05 | |
| 2010-12-31 | $40.63M 8-K · filed 2013-01-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |